APA (7th ed.) Citation

Sethi, V., Rubinstein, I., Kuzmis, A., Kastrissios, H., Artwohl, J., & Onyuksel, H. (2013). Novel, Biocompatible, and Disease Modifying VIP Nanomedicine for Rheumatoid Arthritis. Molecular pharmaceutics, 10(2), 728-738. https://doi.org/10.1021/mp300539f

Chicago Style (17th ed.) Citation

Sethi, Varun, Israel Rubinstein, Antonina Kuzmis, Helen Kastrissios, James Artwohl, and Hayat Onyuksel. "Novel, Biocompatible, and Disease Modifying VIP Nanomedicine for Rheumatoid Arthritis." Molecular Pharmaceutics 10, no. 2 (2013): 728-738. https://doi.org/10.1021/mp300539f.

MLA (9th ed.) Citation

Sethi, Varun, et al. "Novel, Biocompatible, and Disease Modifying VIP Nanomedicine for Rheumatoid Arthritis." Molecular Pharmaceutics, vol. 10, no. 2, 2013, pp. 728-738, https://doi.org/10.1021/mp300539f.